anktiva.com

.com crawl

First seen 2026-05-09 · Last seen 2026-05-09 · ok HTTP/1.1 200 1626 ms crawled 2026-05-15

US · 141.193.213.10 · AS209242 Cloudflare London, LLC

Reputation 95/100 weak security headers

Classifying

HTML metadata

Title
FDA-approved Immunotherapy Treatment for NMIBC CIS - ANKTIVA®
Description
ANKTIVA® is the first FDA-approved drug for non-muscle invasive bladder cancer that activates natural killer cells, T cells, & memory T cells. Learn more now.
Language
en-US
Generator
Anktiva v.2.1.9
Canonical
https://anktiva.com/
Feeds

Open Graph

url
https://anktiva.com/
title
FDA-approved Immunotherapy Treatment for NMIBC CIS - ANKTIVA®
locale
en_US
site name
Anktiva
description
ANKTIVA® is the first FDA-approved drug for non-muscle invasive bladder cancer that activates natural killer cells, T cells, & memory T cells. Learn more now.

Technology

CDN
Cloudflare
CMS
WordPress
Analytics
  • Google Tag Manager
Fonts
  • Adobe Fonts
  • Google Fonts

Third-party hosts loaded (5)

  • fonts.googleapis.com×2
  • assets.adobedtm.com×1
  • pixel.veritone-ce.com×1
  • use.typekit.net×1
  • www.googletagmanager.com×1

Contact

Phone

Registration

Registrar
GoDaddy.com, LLC
Created
2019-02-24
Expires
2027-02-24 279 days left
Updated
2026-02-13
Name servers
  • ns35.domaincontrol.com
  • ns36.domaincontrol.com

DNS records live

NS
  • ns35.domaincontrol.com
  • ns36.domaincontrol.com
MX
  • 0 smtp3.nantworks.com
  • 0 smtp4.nantworks.com
  • 10 smtp5.nantworks.com
Verified for
  • Microsoft 365

Email authentication strong

SPF
v=spf1 include:%{ir}.%{v}.%{d}.spf.has.pphosted.com ~all
softfail (~all)
DMARC
v=DMARC1; p=reject; fo=1; rua=mailto:dmarc_rua@emaildefense.proofpoint.com; ruf=mailto:dmarc_ruf@emaildefense.proofpoint.com;
policy: reject (enforced)
DKIM
no key found at common selectors

Certificate (current)

E8
from 2026-03-31 to 2026-06-29
Expires in 40 days

HTTP security headers

Header hygiene 30/100 Checked live page: https://anktiva.com/

findings
  • missing HSTS
  • missing Content Security Policy
  • missing frame protection
  • missing content type protection
  • missing Referrer Policy
  • missing Permissions Policy

Links to (1)

Linked from (1)